Home » Topics » Regulatory

Regulatory
RSS

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Taxol combination therapy approved in France for NSCLC indication

Oct. 16, 1998

Orphan Medical's Busulfex Injection granted priority review

Oct. 8, 1998

HER2 diagnostic test approved in U.S.; will help identify candidates for Herceptin therapy

Oct. 8, 1998

FDA committee recommends approval of Epivir-HBV

Oct. 7, 1998

FDA approves Serevent Diskus for maintenance treatment of pediatric asthma

Oct. 7, 1998

Italian marketing approval obtained for metoclopramide nasal spray

Oct. 5, 1998

FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder

Oct. 5, 1998

First MMP inhibitor cleared for marketing as adjunct in periodontitis

Oct. 2, 1998

A novel use described for the proton pump inhibitor pantoprazole

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...